Press Release

SKC Formally Appeals NICE Decision

SKC challenged NICE on their decision to deny children the only drug ever specifically developed against neuroblastoma. SKC provided logical arguments against their assessment of cost and efficacy, and championed the plight of these innocent and vulnerable children.  

Read More

2015 Spring Celebration Raises $650,000

The 6th Annual Spring Celebration was held on June 8 at 583 Park Avenue in New York City. 300 guests attended the event and helped raise $300,000 during the live auction to create three new clinical trials using combination PD-1 inhibitors for children with deadly brain tumors and neuroblastoma.

Read More

2015 CCAM

Anonymous Donor Pledges $1 Per Share to Solving Kids` Cancer throughout September

Read More

Clinical Trial Opens Using Natural Killer Cells

New York City—(October 10, 2013) Researchers have made rapid advances in understandinghow to manipulate the immune system safely to destroy cancer cells. Adoptive transfer ofhaploidentical natural killer (NK) cells has shown promise as a treatment option to target andkill cancer cells in a less toxic way than conventional therapies. Now for the first time, scientists will…

Read More

Adoptive Cell Therapy

Pediatric cancer scientists involved in the T-cell/HIV study that cured a 9-year-old leukemia patient will develop a new experimental cancer immunotherapy treatment option for children with high-risk solid tumors that uses a patient`s own T-cells to attack tumor cells. 

Read More